Cardlytics, Inc. (CDLX) — 10-Q Filings

10-Q Filings (5)

• Cardlytics' Losses Widen Amidst Equity Decline — Aug 6, 2025 Risk: high
  Cardlytics, Inc. reported a net loss of $17.5 million for the three months ended June 30, 2025, a significant increase from the net loss of $10.2 million for th
• Cardlytics Q1 2025 10-Q Filed — May 7, 2025 Risk: low
  Cardlytics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including changes
• Cardlytics Q3 2024 10-Q Filed — Nov 6, 2024 Risk: medium
  Cardlytics, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter of 2024, detailing its re
• Cardlytics Files Q2 2024 10-Q — Aug 7, 2024 Risk: medium
  Cardlytics, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of
• Cardlytics, Inc. Files 10-Q for Period Ending March 31, 2024 — May 8, 2024 Risk: low
  Cardlytics, Inc. (CDLX) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Cardlytics, Inc. filed its 10-Q report for the period ending March 31, 2024

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX